198 related articles for article (PubMed ID: 19494006)
61. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.
Champsaur M; Beilke JN; Ogasawara K; Koszinowski UH; Jonjic S; Lanier LL
J Immunol; 2010 Jul; 185(1):157-65. PubMed ID: 20530257
[TBL] [Abstract][Full Text] [Related]
62. Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus.
Scalzo AA; Wheat R; Dubbelde C; Stone L; Clark P; Du Y; Dong N; Stoll J; Yokoyama WM; Brown MG
Immunogenetics; 2003 Sep; 55(6):370-8. PubMed ID: 12920489
[TBL] [Abstract][Full Text] [Related]
63. Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.
Forbes CA; Scalzo AA; Degli-Esposti MA; Coudert JD
J Immunol; 2016 Jul; 197(1):128-40. PubMed ID: 27233959
[TBL] [Abstract][Full Text] [Related]
64. Resisting viral infection: the gene by gene approach.
Moresco EM; Beutler B
Curr Opin Virol; 2011 Dec; 1(6):513-8. PubMed ID: 22440911
[TBL] [Abstract][Full Text] [Related]
65. Murine NKG2D ligands: "double, double toil and trouble".
Samarakoon A; Chu H; Malarkannan S
Mol Immunol; 2009 Mar; 46(6):1011-9. PubMed ID: 19081632
[TBL] [Abstract][Full Text] [Related]
66. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
67. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
[TBL] [Abstract][Full Text] [Related]
68. NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.
Maier LM; Howlett SK; Rainbow KM; Clark J; Howson JM; Todd JA; Wicker LS
J Immunol; 2008 Nov; 181(10):7073-80. PubMed ID: 18981127
[TBL] [Abstract][Full Text] [Related]
69. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.
Nausch N; Florin L; Hartenstein B; Angel P; Schorpp-Kistner M; Cerwenka A
J Immunol; 2006 Jan; 176(1):7-11. PubMed ID: 16365389
[TBL] [Abstract][Full Text] [Related]
70. Escape of mutant double-stranded DNA virus from innate immune control.
French AR; Pingel JT; Wagner M; Bubic I; Yang L; Kim S; Koszinowski U; Jonjic S; Yokoyama WM
Immunity; 2004 Jun; 20(6):747-56. PubMed ID: 15189739
[TBL] [Abstract][Full Text] [Related]
71. Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
Cho HM; Rosenblatt JD; Tolba K; Shin SJ; Shin DS; Calfa C; Zhang Y; Shin SU
Cancer Res; 2010 Dec; 70(24):10121-30. PubMed ID: 21159634
[TBL] [Abstract][Full Text] [Related]
72. Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control.
Zarama A; Pérez-Carmona N; Farré D; Tomic A; Borst EM; Messerle M; Jonjic S; Engel P; Angulo A
PLoS Pathog; 2014 Mar; 10(3):e1004000. PubMed ID: 24626474
[TBL] [Abstract][Full Text] [Related]
73. Immunology. A pathogen receptor on natural killer cells.
Vivier E; Biron CA
Science; 2002 May; 296(5571):1248-9. PubMed ID: 12016296
[No Abstract] [Full Text] [Related]
74. Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion.
Wang R; Natarajan K; Revilleza MJ; Boyd LF; Zhi L; Zhao H; Robinson H; Margulies DH
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3578-87. PubMed ID: 23169621
[TBL] [Abstract][Full Text] [Related]
75. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.
Cranmer LD; Clark CL; Morello CS; Farrell HE; Rawlinson WD; Spector DH
J Virol; 1996 Nov; 70(11):7929-39. PubMed ID: 8892916
[TBL] [Abstract][Full Text] [Related]
76. Construction of a plasmid for co-expression of mouse membrane-bound form of IL-15 and RAE-1ε and its biological activity.
Qian L; Ji MC; Pan XY; Gong WJ; Tian F; Duan QF
Plasmid; 2011 May; 65(3):239-45. PubMed ID: 21377489
[TBL] [Abstract][Full Text] [Related]
77. Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153.
Mans J; Natarajan K; Balbo A; Schuck P; Eikel D; Hess S; Robinson H; Simic H; Jonjic S; Tiemessen CT; Margulies DH
J Biol Chem; 2007 Nov; 282(48):35247-58. PubMed ID: 17897947
[TBL] [Abstract][Full Text] [Related]
78. Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection.
Nabekura T; Lanier LL
Immunity; 2016 Jul; 45(1):74-82. PubMed ID: 27438766
[TBL] [Abstract][Full Text] [Related]
79. Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
Geurs TL; Zhao YM; Hill EB; French AR
J Immunol; 2009 Nov; 183(9):5830-6. PubMed ID: 19828630
[TBL] [Abstract][Full Text] [Related]
80. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice.
Lee SH; Zafer A; de Repentigny Y; Kothary R; Tremblay ML; Gros P; Duplay P; Webb JR; Vidal SM
J Exp Med; 2003 Feb; 197(4):515-26. PubMed ID: 12591908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
